Literature DB >> 26994712

Evidence and the Politics of Deimplementation: The Rise and Decline of the "Counseling and Testing" Paradigm for HIV Prevention at the US Centers for Disease Control and Prevention.

David Merritt Johns1, Ronald Bayer1, Amy L Fairchild1.   

Abstract

POLICY POINTS: In situations of scientific uncertainty, public health interventions, such as counseling for HIV infection, sometimes must be implemented before obtaining evidence of efficacy. The history of HIV counseling and testing, which served as the cornerstone of HIV prevention efforts at the US Centers for Disease Control and Prevention (CDC) for a quarter of a century, illustrates the influence of institutional resistance on public health decision making and the challenge of de-implementing well-established programs. CONTEXT: In 1985, amid uncertainty about the accuracy of the new test for HIV, public health officials at the Centers for Disease Control and Prevention (CDC) and AIDS activists agreed that counseling should always be provided both before and after testing to ensure that patients were tested voluntarily and understood the meaning of their results. As the "exceptionalist" perspective that framed HIV in the early years began to recede, the purpose of HIV test counseling shifted over the next 30 years from emphasizing consent, to providing information, to encouraging behavioral change. With this increasing emphasis on prevention, HIV test counseling faced mounting doubts about whether it "worked." The CDC finally discontinued its preferred test counseling approach in October 2014.
METHODS: Drawing on key informant interviews with current and former CDC officials, behavioral scientists, AIDS activists, and others, along with archival material, news reports, and scientific and governmental publications, we examined the origins, development, and decline of the CDC's "counseling and testing" paradigm for HIV prevention.
FINDINGS: Disagreements within the CDC emerged by the 1990s over whether test counseling could be justified on the basis of efficacy and cost. Resistance to the prospect of policy change by supporters of test counseling in the CDC, gay activists for whom counseling carried important ethical and symbolic meanings, and community organizations dependent on federal funding made it difficult for the CDC to de-implement the practice.
CONCLUSIONS: Analyses of changes in public health policy that emphasize the impact of research evidence produced in experimental or epidemiological inquiries may overlook key social and political factors involving resistance to deimplementation that powerfully shape the relationship between science and policy.
© 2016 Milbank Memorial Fund.

Entities:  

Keywords:  Centers for Disease Control and Prevention; HIV infections; HIV test; counseling

Mesh:

Year:  2016        PMID: 26994712      PMCID: PMC4941977          DOI: 10.1111/1468-0009.12183

Source DB:  PubMed          Journal:  Milbank Q        ISSN: 0887-378X            Impact factor:   4.911


  53 in total

1.  Can antiretroviral therapy eliminate HIV transmission?

Authors:  Kevin M De Cock; Charles F Gilks; Ying-Ru Lo; Teguest Guerma
Journal:  Lancet       Date:  2008-11-27       Impact factor: 79.321

2.  Caring for people with human immunodeficiency virus infection.

Authors:  R Steinbrook
Journal:  N Engl J Med       Date:  1998-12-24       Impact factor: 91.245

3.  On the undiffusion of established practices.

Authors:  Frank Davidoff
Journal:  JAMA Intern Med       Date:  2015-05       Impact factor: 21.873

4.  Public Health Service guidelines for counseling and antibody testing to prevent HIV infection and AIDS.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1987-08-14       Impact factor: 17.586

5.  Technical guidance on HIV counseling. Center for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1993-01-15

6.  Eliminating prevention counseling to improve HIV screening.

Authors:  Jason S Haukoos; Mark W Thrun
Journal:  JAMA       Date:  2013-10-23       Impact factor: 56.272

7.  Effect of risk-reduction counseling with rapid HIV testing on risk of acquiring sexually transmitted infections: the AWARE randomized clinical trial.

Authors:  Lisa R Metsch; Daniel J Feaster; Lauren Gooden; Bruce R Schackman; Tim Matheson; Moupali Das; Matthew R Golden; Shannon Huffaker; Louise F Haynes; Susan Tross; C Kevin Malotte; Antoine Douaihy; P Todd Korthuis; Wayne A Duffus; Sarah Henn; Robert Bolan; Susan S Philip; Jose G Castro; Pedro C Castellon; Gayle McLaughlin; Raul N Mandler; Bernard Branson; Grant N Colfax
Journal:  JAMA       Date:  2013-10-23       Impact factor: 56.272

Review 8.  Evidence for the effects of HIV antibody counseling and testing on risk behaviors.

Authors:  D L Higgins; C Galavotti; K R O'Reilly; D J Schnell; M Moore; D L Rugg; R Johnson
Journal:  JAMA       Date:  1991-11-06       Impact factor: 56.272

9.  Impact of counseling in voluntary counseling and testing programs for persons at risk for or living with HIV infection.

Authors:  David Holtgrave; Jean McGuire
Journal:  Clin Infect Dis       Date:  2007-12-15       Impact factor: 9.079

10.  Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group.

Authors:  M L Kamb; M Fishbein; J M Douglas; F Rhodes; J Rogers; G Bolan; J Zenilman; T Hoxworth; C K Malotte; M Iatesta; C Kent; A Lentz; S Graziano; R H Byers; T A Peterman
Journal:  JAMA       Date:  1998-10-07       Impact factor: 56.272

View more
  15 in total

1.  The End of Written Informed Consent for HIV Testing: Not With a Bang but a Whimper.

Authors:  Ronald Bayer; Morgan Philbin; Robert H Remien
Journal:  Am J Public Health       Date:  2017-06-22       Impact factor: 9.308

2.  UNAIDS 90-90-90 Campaign to End the AIDS Epidemic in Historic Perspective.

Authors:  Powel Kazanjian
Journal:  Milbank Q       Date:  2017-06       Impact factor: 4.911

3.  Implementation of Clinical Practice Guidelines in the Health Care Setting: A Concept Analysis.

Authors:  Melissa Beauchemin; Elizabeth Cohn; Rachel C Shelton
Journal:  ANS Adv Nurs Sci       Date:  2019 Oct/Dec       Impact factor: 1.824

4.  Use of effective training and quality assurance strategies is associated with high-fidelity EBI implementation in practice settings: a case analysis.

Authors:  M Margaret Dolcini; Melissa A Davey-Rothwell; Ryan R Singh; Joseph A Catania; Alice A Gandelman; Vasudha Narayanan; Justin Harris; Virginia R McKay
Journal:  Transl Behav Med       Date:  2021-02-11       Impact factor: 3.046

5.  Defining and conceptualizing outcomes for de-implementation: key distinctions from implementation outcomes.

Authors:  Beth Prusaczyk; Taren Swindle; Geoffrey Curran
Journal:  Implement Sci Commun       Date:  2020-04-30

6.  The de-implementation and persistence of low-value HIV prevention interventions in the United States: a cross-sectional study.

Authors:  Virginia R McKay; Todd B Combs; M Margaret Dolcini; Ross C Brownson
Journal:  Implement Sci Commun       Date:  2020-06-30

Review 7.  Better Service by Doing Less: Introducing De-implementation Research in HIV.

Authors:  Virginia R McKay; Emmanuel K Tetteh; Miranda J Reid; Lucy M Ingaiza
Journal:  Curr HIV/AIDS Rep       Date:  2020-10       Impact factor: 5.071

Review 8.  Letting Go: Conceptualizing Intervention De-implementation in Public Health and Social Service Settings.

Authors:  Virginia R McKay; Alexandra B Morshed; Ross C Brownson; Enola K Proctor; Beth Prusaczyk
Journal:  Am J Community Psychol       Date:  2018-07-03

9.  Perspectives on program mis-implementation among U.S. local public health departments.

Authors:  Peg Allen; Rebekah R Jacob; Renee G Parks; Stephanie Mazzucca; Hengrui Hu; Mackenzie Robinson; Maureen Dobbins; Debra Dekker; Margaret Padek; Ross C Brownson
Journal:  BMC Health Serv Res       Date:  2020-03-30       Impact factor: 2.655

10.  The dynamic influence of human resources on evidence-based intervention sustainability and population outcomes: an agent-based modeling approach.

Authors:  Virginia R McKay; Lee D Hoffer; Todd B Combs; M Margaret Dolcini
Journal:  Implement Sci       Date:  2018-06-05       Impact factor: 7.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.